|
1
|
Sada Y, Dohi Y, Uga S, Higashi A,
Kinoshita H and Kihara Y: Non-suppressive regulatory T cell subset
expansion in pulmonary arterial hypertension. Heart Vessels.
31:1319–1326. 2016. View Article : Google Scholar
|
|
2
|
Gao L, Liu J, Hao Y, Zhao Z, Tan H, Zhang
J, Meng N, Zheng Q, Wang Z and Zhang Y: Chronic intermittent
hypobaric hypoxia attenuates monocrotaline-induced pulmonary
arterial hypertension via modulating inflammation and suppressing
NF-κB/p38 pathway. Iran J Basic Med Sci. 21:244–252.
2018.PubMed/NCBI
|
|
3
|
Deng Y, Guo SL, Wei B, Gao XC, Zhou YC and
Li JQ: Activation of nicotinic acetylcholine α7 receptor attenuates
progression of monocrotaline-induced pulmonary hypertension in rats
by downregulating the NLRP3 inflammasome. Front Pharmacol.
10:1282019. View Article : Google Scholar
|
|
4
|
Chen F, Wang H, Zhao J, Yan J, Meng H,
Zhan H, Chen L and Yuan L: Grape seed proanthocyanidin inhibits
monocro-taline-induced pulmonary arterial hypertension via
attenuating inflammation: In vivo and in vitro studies. J Nutr
Biochem. 67:72–77. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Austin ED, Rock MT, Mosse CA,
Vnencak-Jones CL, Yoder SM, Robbins IM, Loyd JE and Meyrick BO: T
lymphocyte subset abnormalities in the blood and lung in pulmonary
arterial hypertension. Respir Med. 104:454–462. 2010. View Article : Google Scholar :
|
|
6
|
Savai R, Pullamsetti SS, Kolbe J, Bieniek
E, Voswinckel R, Fink L, Scheed A, Ritter C, Dahal BK, Vater A, et
al: Immune and inflammatory cell involvement in the pathology of
idiopathic pulmonary arterial hypertension. Am J Respir Crit Care
Med. 186:897–908. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rabinovitch M, Guignabert C, Humbert M and
Nicolls MR: Inflammation and immunity in the pathogenesis of
pulmonary arterial hypertension. Circ Res. 115:165–175. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yang JM, Zhou R, Zhang M, Tan HR and Yu
JQ: Betaine attenuates monocrotaline-induced pulmonary arterial
hypertension in rats via inhibiting inflammatory response.
Molecules. 23:E12742018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pang Y, Liang MT, Gong Y, Yang Y, Bu PL,
Zhang M and Yao HC: HGF reduces disease severity and inflammation
by attenuating the NF-κB signaling in a rat model of pulmonary
artery hypertension. Inflammation. 41:924–931. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li XQ, Wang HM, Yang CG, Zhang XH, Han DD
and Wang HL: Fluoxetine inhibited extracellular matrix of pulmonary
artery and inflammation of lungs in monocrotaline-treated rats.
Acta Pharmacol Sin. 32:217–222. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Nogueira-Ferreira R, Vitorino R, Ferreira
R and Henriques-Coelho T: Exploring the monocrotaline animal model
for the study of pulmonary arterial hypertension: A network
approach. Pulm Pharmacol Ther. 35:8–16. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang B, Niu W, Xu D, Li Y, Liu M, Wang Y,
Luo Y, Zhao P, Liu Y, Dong M, et al: Oxymatrine prevents hypoxia-
and mono-crotaline-induced pulmonary hypertension in rats. Free
Radic Biol Med. 69:198–207. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cohen-Kaminsky S, Hautefort A, Price L,
Humbert M and Perros F: Inflammation in pulmonary hypertension:
What we know and what we could logically and safely target first.
Drug Discov Today. 19:1251–1256. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang W, Wang YL, Chen XY, Li YT, Hao W,
Jin YP and Han B: Dexamethasone attenuates development of
monocrotaline-induced pulmonary arterial hypertension. Mol Biol
Rep. 38:3277–3284. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhao H, Xue Y, Guo Y, Sun Y, Liu D and
Wang X: Inhibition of endocan attenuates monocrotaline-induced
connective tissue disease related pulmonary arterial hypertension.
Int Immunopharmacol. 42:115–121. 2017. View Article : Google Scholar
|
|
16
|
Ni X, Li XZ, Fan ZR, Wang A, Zhang HC,
Zhang L, Li L, Si JQ and Ma KT: Increased expression and
functionality of the gap junction in peripheral blood lymphocytes
is associated with hypertension-mediated inflammation in
spontaneously hypertensive rats. Cell Mol Biol Lett. 23:402018.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ni X, Wang A, Zhang L, Shan LY, Zhang HC,
Li L, Si JQ, Luo J, Li XZ and Ma KT: Up-regulation of gap junction
in peripheral blood T lymphocytes contributes to the inflammatory
response in essential hypertension. PLoS One. 12:e01847732017.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang HC, Zhang ZS, Zhang L, Wang A, Zhu
H, Li L, Si JQ, Li XZ and Ma KT: Connexin 43 in splenic lymphocytes
is involved in the regulation of CD4+CD25+ T
lymphocyte proliferation and cytokine production in hypertensive
inflammation. Int J Mol Med. 41:13–24. 2018.
|
|
19
|
Ni X, Zhang L, Ma X, Shan LY, Li L, Si JQ,
Li XZ, Zhang YY and Ma KT: β-estradiol alleviates hypertension- and
concanavalin A-mediated inflammatory responses via modulation of
connexins in peripheral blood lymphocytes. Mol Med Rep.
19:3743–3755. 2019.PubMed/NCBI
|
|
20
|
Ni X, Zhang L, Peng M, Shen TW, Yu XS,
Shan LY, Li L, Si JQ, Li XZ and Ma KT: Hydrogen sulfide attenuates
hypertensive inflammation via regulating connexin expression in
spontaneously hypertensive rats. Med Sci Monit. 24:1205–1218. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Manjarrez-Marmolejo J and Franco-Pérez J:
Gap Junction Blockers: An overview of their effects on induced
seizures in animal models. Curr Neuropharmacol. 14:759–771. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
O'Donnell JJ III, Birukova AA, Beyer EC
and Birukov KG: Gap junction protein connexin43 exacerbates lung
vascular permeability. PLoS One. 9:e1009312014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Suzuki S, Matsuda Y, Sugawara T, Tabata T,
Ishibashi H, Hoshikawa Y, Kubo H and Kondo T: Effects of
carbenoxolone on alveolar fluid clearance and lung inflammation in
the rat. Crit Care Med. 32:1910–1915. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ram A, Singh SK, Singh VP, Kumar S and
Ghosh B: Inhaled carbenoxolone prevents allergic airway
inflammation and airway hyperreactivity in a mouse model of asthma.
Int Arch Allergy Immunol. 149:38–46. 2009. View Article : Google Scholar
|
|
25
|
Endong L, Shijie J, Sonobe Y, Di M, Hua L,
Kawanokuchi J, Mizuno T and Suzumura A: The gap-junction inhibitor
carben-oxolone suppresses the differentiation of Th17 cells through
inhibition of IL-23 expression in antigen presenting cells. J
Neuroimmunol. 240-241:58–64. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bayne K: Revised Guide for the Care and
Use of Laboratory Animals Available. American Physiological
Society. Physiologist. 39:199208–211. 1996.PubMed/NCBI
|
|
27
|
Sharma S, Sharma N, Saini A and Nehru B:
Carbenoxolone reverses the amyloid Beta 1-42 oligomer-induced
oxidative damage and anxiety-related behavior in rats. Neurotox
Res. 35:654–667. 2019. View Article : Google Scholar
|
|
28
|
Urboniene D, Haber I, Fang YH, Thenappan T
and Archer SL: Validation of high-resolution echocardiography and
magnetic resonance imaging vs. high-fidelity catheterization in
experimental pulmonary hypertension. Am J Physiol Lung Cell Mol
Physiol. 299:L401–L412. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Temple IP, Monfredi O, Quigley G,
Schneider H, Zi M, Cartwright EJ, Boyett MR, Mahadevan VS and Hart
G: Macitentan treatment retards the progression of established
pulmonary arterial hypertension in an animal model. Int J Cardiol.
177:423–428. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Flues K, Moraes-Silva IC, Mostarda C,
Souza PR, Diniz GP, Moreira ED, Piratello AC, Chaves ML, De Angelis
K, Salemi VM, et al: Cardiac and pulmonary arterial remodeling
after sinoaortic dener-vation in normotensive rats. Auton Neurosci.
166:47–53. 2012. View Article : Google Scholar
|
|
31
|
Lang RM, Bierig M, Devereux RB,
Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward
J, Shanewise JS, et al Chamber Quantification Writing Group;
American Society of Echocardiography's Guidelines and Standards
Committee; European Association of Echocardiography:
Recommendations for chamber quantification: A report from the
American Society of Echocardiography's Guidelines and Standards
Committee and the Chamber Quantification Writing Group, developed
in conjunction with the European Association of Echocardiography, a
branch of the European Society of Cardiology. J Am Soc
Echocardiogr. 18:1440–1463. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ji WJ, Ma YQ, Zhou X, Zhang YD, Lu RY, Guo
ZZ, Sun HY, Hu DC, Yang GH, Li YM, et al: Spironolactone attenuates
bleomycin-induced pulmonary injury partially via modulating
mononuclear phagocyte phenotype switching in circulating and
alveolar compartments. PLoS One. 8:e810902013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lei L, He ZY, Zhao C, Sun XJ and Zhong XN:
Elevated frequencies of CD4(+) IL-21(+) T, CD4(+) IL-21R(+) T and
IL-21(+) Th17 cells, and increased levels of IL-21 in
bleomycin-induced mice may be associated with dermal and pulmonary
inflammation and fibrosis. Int J Rheum Dis. 19:392–404. 2016.
View Article : Google Scholar
|
|
34
|
Barletta KE, Cagnina RE, Wallace KL, Ramos
SI, Mehrad B and Linden J: Leukocyte compartments in the mouse
lung: Distinguishing between marginated, interstitial, and alveolar
cells in response to injury. J Immunol Methods. 375:100–110. 2012.
View Article : Google Scholar :
|
|
35
|
Martinu T, Kinnier CV, Sun J, Kelly FL,
Nelson ME, Garantziotis S, Foster WM and Palmer SM: Allogeneic
sple-nocyte transfer and lipopolysaccharide inhalations induce
differential T cell expansion and lung injury: A novel model of
pulmonary graft-versus-host disease. PLoS One. 9:e979512014.
View Article : Google Scholar
|
|
36
|
Alencar AKN, Pimentel-Coelho PM, Montes
GC, da Silva MMC, Mendes LVP, Montagnoli TL, Silva AMS, Vasques JF,
Rosado-de-Castro PH, Gutfilen B, et al: Human mesenchymal stem cell
therapy reverses Su5416/hypoxia-induced pulmonary arterial
hypertension in mice. Front Pharmacol. 9:13952018. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Li L, Wei C, Kim IK, Janssen-Heininger Y
and Gupta S: Inhibition of nuclear factor-κB in the lungs prevents
monocrotaline-induced pulmonary hypertension in mice. Hypertension.
63:1260–1269. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yamazato Y, Yamazato M, Ishida A, Fujita J
and Ohya Y: Intratracheal administration of autologous bone
marrow-derived cells ameliorates monocrotaline-induced pulmonary
vessel remodeling and lung inflammation in rats. Lung. 196:147–155.
2018. View Article : Google Scholar
|
|
39
|
Marsh LM, Jandl K, Grünig G, Foris V,
Bashir M, Ghanim B, Klepetko W, Olschewski H, Olschewski A and
Kwapiszewska G: The inflammatory cell landscape in the lungs of
patients with idiopathic pulmonary arterial hypertension. Eur
Respir J. 51:17012142018. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Sáez PJ, Shoji KF, Aguirre A and Sáez JC:
Regulation of hemichannels and gap junction channels by cytokines
in antigen-presenting cells. Mediators Inflamm. 2014:7427342014.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Oviedo-Orta E, Hoy T and Evans WH:
Intercellular communication in the immune system: Differential
expression of connexin40 and 43, and perturbation of gap junction
channel functions in peripheral blood and tonsil human lymphocyte
subpopulations. Immunology. 99:578–590. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Mendoza-Naranjo A, Bouma G, Pereda C,
Ramírez M, Webb KF, Tittarelli A, López MN, Kalergis AM, Thrasher
AJ, Becker DL, et al: Functional gap junctions accumulate at the
immunological synapse and contribute to T cell activation. J
Immunol. 187:3121–3132. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Freund-Michel V, Muller B, Marthan R,
Savineau JP and Guibert C: Expression and role of connexin-based
gap junctions in pulmonary inflammatory diseases. Pharmacol Ther.
164:105–119. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Feng S, Chen S, Yu W, Zhang D, Zhang C,
Tang C, Du J and Jin H: H2S inhibits pulmonary arterial endothelial
cell inflammation in rats with monocrotaline-induced pulmonary
hypertension. Lab Invest. 97:268–278. 2017. View Article : Google Scholar
|
|
45
|
Willebrords J, Crespo Yanguas S, Maes M,
Decrock E, Wang N, Leybaert L, Kwak BR, Green CR, Cogliati B and
Vinken M: Connexins and their channels in inflammation. Crit Rev
Biochem Mol Biol. 51:413–439. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Meloche J, Renard S, Provencher S and
Bonnet S: Anti-inflammatory and immunosuppressive agents in PAH.
Handb Exp Pharmacol. 218:437–476. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Sharma AK, Charles EJ, Zhao Y, Narahari
AK, Baderdinni PK, Good ME, Lorenz UM, Kron IL, Bayliss DA,
Ravichandran KS, et al: Pannexin-1 channels on endothelial cells
mediate vascular inflammation during lung ischemia-reperfusion
injury. Am J Physiol Lung Cell Mol Physiol. 315:L301–L312. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Billaud M, Dahan D, Marthan R, Savineau JP
and Guibert C: Role of the gap junctions in the contractile
response to agonists in pulmonary artery from two rat models of
pulmonary hypertension. Respir Res. 12:302011. View Article : Google Scholar : PubMed/NCBI
|
